A. Bertolino

462 total citations
28 papers, 388 citations indexed

About

A. Bertolino is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, A. Bertolino has authored 28 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in A. Bertolino's work include Sphingolipid Metabolism and Signaling (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Treatment of Major Depression (4 papers). A. Bertolino is often cited by papers focused on Sphingolipid Metabolism and Signaling (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Treatment of Major Depression (4 papers). A. Bertolino collaborates with scholars based in Italy, United States and France. A. Bertolino's co-authors include Marcella Renis, Fiorentina Roviezzo, Giuseppe Cirino, Rosalinda Sorrentino, V. Porro, Michela Terlizzi, Bruno D’Agostino, Laurent Miccoli, Venerando Rapisarda and N. Ciani and has published in prestigious journals such as British Journal of Pharmacology, Life Sciences and American Journal of Respiratory Cell and Molecular Biology.

In The Last Decade

A. Bertolino

28 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Bertolino Italy 11 130 90 71 71 51 28 388
David Winger United States 8 163 1.3× 136 1.5× 200 2.8× 92 1.3× 75 1.5× 8 478
Zsófia Mezei Hungary 13 128 1.0× 81 0.9× 39 0.5× 86 1.2× 60 1.2× 28 370
Katrin Andreasson United States 7 115 0.9× 65 0.7× 97 1.4× 86 1.2× 38 0.7× 11 386
Á Gecse Hungary 13 219 1.7× 65 0.7× 54 0.8× 81 1.1× 68 1.3× 43 478
Hiroko Tonai‐Kachi Japan 8 200 1.5× 67 0.7× 105 1.5× 104 1.5× 22 0.4× 8 388
Kevin J. Kiwak United States 7 171 1.3× 121 1.3× 68 1.0× 89 1.3× 132 2.6× 8 590
Miho Shukuri Japan 10 105 0.8× 85 0.9× 82 1.2× 62 0.9× 25 0.5× 19 393
Robert J. Gregg United States 11 168 1.3× 106 1.2× 34 0.5× 86 1.2× 13 0.3× 19 663
L. David Waterbury United States 14 141 1.1× 66 0.7× 204 2.9× 38 0.5× 36 0.7× 39 723
Ruth Seemann United States 12 185 1.4× 54 0.6× 36 0.5× 172 2.4× 51 1.0× 13 511

Countries citing papers authored by A. Bertolino

Since Specialization
Citations

This map shows the geographic impact of A. Bertolino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bertolino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bertolino more than expected).

Fields of papers citing papers by A. Bertolino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bertolino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bertolino. The network helps show where A. Bertolino may publish in the future.

Co-authorship network of co-authors of A. Bertolino

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bertolino. A scholar is included among the top collaborators of A. Bertolino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bertolino. A. Bertolino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Popovic, David, Anne Ruef, Raimo K. R. Salokangas, et al.. (2024). Multivariate associations between psychiatric drug intake and grey matter volume changes in individuals at early stages of psychosis and depression. European Psychiatry. 67(S1). S272–S273. 1 indexed citations
2.
Riemma, Maria Antonietta, Ida Cerqua, Barbara Romano, et al.. (2021). Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease. British Journal of Pharmacology. 179(8). 1753–1768. 27 indexed citations
3.
Maré, Jean‐Charles, et al.. (2019). Increasing the fidelity of EMAs real-time simulation. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
4.
Roviezzo, Fiorentina, Rosalinda Sorrentino, Vincenzo Brancaleone, et al.. (2016). Disodium cromoglycate inhibits asthma-like features induced by sphingosine-1-phosphate. Pharmacological Research. 113(Pt A). 626–635. 22 indexed citations
5.
Roviezzo, Fiorentina, Vincenzo Brancaleone, A. Bertolino, et al.. (2016). Proteinase activated receptor‐2 counterbalances the vascular effects of endothelin‐1 in fibrotic tight‐skin mice. British Journal of Pharmacology. 174(22). 4032–4042. 3 indexed citations
6.
Roviezzo, Fiorentina, A. Bertolino, Rosalinda Sorrentino, et al.. (2015). Hydrogen sulfide inhalation ameliorates allergen induced airway hypereactivity by modulating mast cell activation. Pharmacological Research. 100. 85–92. 41 indexed citations
7.
Sorrentino, Rosalinda, A. Bertolino, Michela Terlizzi, et al.. (2014). B Cell Depletion Increases Sphingosine-1-Phosphate–Dependent Airway Inflammation in Mice. American Journal of Respiratory Cell and Molecular Biology. 52(5). 571–583. 20 indexed citations
8.
Emery, P., Dominique Baeten, Joachim Sieper, et al.. (2012). EVALUATION OF EFFICACY AND SAFETY OF SECUKINUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS. Lara D. Veeken. 51. 21–21. 6 indexed citations
9.
McInnes, Iain B., John D. Isaacs, Hendrik Schulze‐Koops, et al.. (2011). Anti-Interleukin 17A Monoclonal Antibody Secukinumab Reduces Signs and Symptoms of Psoriatic Arthritis in a 24-Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Data Archiving and Networked Services (DANS). 2 indexed citations
10.
Guazzelli, M., et al.. (1995). P-4-29 Clinical effects of I-sulpiride vs haloperidol in acutely relapsed chronic schizophrenics: Therapeutic efficacy on “disorganization”?. European Neuropsychopharmacology. 5(3). 336–336. 2 indexed citations
11.
Invernizzi, G, Eugenio Aguglia, A. Bertolino, et al.. (1994). The Efficacy and Safety of Tianeptine in the Treatment of Depressive Disorder: Results of a Controlled Double-Blind Multicentre Study vs. Amitriptyline. Neuropsychobiology. 30(2-3). 85–93. 33 indexed citations
12.
Bersani, Giuseppe, Venerando Rapisarda, N. Ciani, A. Bertolino, & Giovanni Sorge. (1994). A double‐blind comparative study of sertraline and amitriptyline in outpatients with major depressive episodes. Human Psychopharmacology Clinical and Experimental. 9(1). 63–68. 18 indexed citations
13.
Ciani, N., Giovanni Corsini, Maria Del Zompo, et al.. (1993). Long-term treatment of depression by tianeptine. European Neuropsychopharmacology. 3(3). 333–334. 1 indexed citations
14.
Porro, V., et al.. (1988). Single-blind comparison of the efficacy of fluvoxamine versus placebo in patients with depressive syndrome. Current Therapeutic Research. 43(4). 621–629. 7 indexed citations
15.
Miccoli, Laurent, V. Porro, & A. Bertolino. (1979). Comparison between the antidepressant activity and of S-adenosylmethionine (SAMe) and that of some tricyclic drugs.. PubMed. 33(3). 243–55. 26 indexed citations
16.
Livrea, Paolo, et al.. (1978). Homovanillic acid and 5-hydroxyindoleacetic acid in human brain areas at autopsy. Effect of pre-death conditions with special attention to the state of consciousness and metabolic diseases.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 33(6). 487–500. 2 indexed citations
17.
18.
19.
Renis, Marcella, et al.. (1977). In vivo studies of catechol-o-methyl transferase activity following intoxication with ethanol, L-dopa and dopamine-derived alkaloids. Pharmacological Research Communications. 9(2). 203–214. 6 indexed citations
20.
Livrea, Paolo, et al.. (1976). Effects of Tetrahydropapaveroline on Dopamine and 5-Hydroxytryptamine Metabolism in Rat Brain <i>in vivo</i>. Pharmacology. 14(1). 20–26. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Winger Breakdown of academic impact, for papers by Zsófia Mezei Breakdown of academic impact, for papers by Katrin Andreasson Breakdown of academic impact, for papers by Á Gecse Breakdown of academic impact, for papers by Hiroko Tonai‐Kachi Breakdown of academic impact, for papers by Kevin J. Kiwak Breakdown of academic impact, for papers by Miho Shukuri Breakdown of academic impact, for papers by Robert J. Gregg Breakdown of academic impact, for papers by L. David Waterbury Breakdown of academic impact, for papers by Ruth Seemann
Rankless by CCL
2026